Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 26.
doi: 10.1111/jre.13396. Online ahead of print.

Enamel Matrix Derivative in the Reconstructive Surgical Therapy of Peri-Implantitis: A Randomized Clinical Trial

Erik Regidor  1 , Carlotta Dionigi  2 , Martina Ghoraishi  2 , Jon Salazar  1 , Anna Trullenque-Eriksson  2 , Jan Derks  2 , Alberto Ortiz-Vigón  1
Affiliations

Enamel Matrix Derivative in the Reconstructive Surgical Therapy of Peri-Implantitis: A Randomized Clinical Trial

Erik Regidor et al. J Periodontal Res. .

Abstract

Aims: To evaluate the adjunctive effect of enamel matrix derivative (EMD) in the reconstructive surgical therapy of peri-implantitis.

Methods: Forty subjects (44 implants) affected by peri-implantitis (PPD ≥ 5 mm, positive BOP/SOP, intraosseous defect with a depth of ≥ 3 mm and width of ≤ 4 mm) were randomly allocated to one of two surgical protocols: control (access flap + bone graft + resorbable membrane) or test (access flap + bone graft + resorbable membrane + EMD). Clinical outcomes (PPD, BOP, SOP, buccal REC, and buccal KM) were assessed at baseline, 6 and 12 months after surgery. Radiographic marginal bone levels (MBL) and patient-reported outcomes (PROs) were recorded at baseline and at 12 months. Post-operative complications and Early Healing Index (EHI) scores were recorded at 2 weeks. The primary outcome was PPD change. Two composite outcomes (CO) were assessed: CO1 was defined as "implant not lost, PPD ≤ 5 mm, REC ≤ 1 mm and complete absence of BOP/SOP"; CO2 defined as CO1 but allowing for 1 site with BOP.

Results: Four patients (four implants) were lost to follow-up. At 12 months, no implants were lost, 73% of implants presented with PPD ≤ 5 mm (control: 65.2%; test: 81.0%; p = 0.316) and PPD reduction amounted to 4.0 ± 1.7 and 4.3 ± 2.4 mm in control and test groups, respectively (p = 0.105). No significant differences in terms of clinical, radiographic, composite and PROs were observed between groups. No significant differences in EHI scores were found at 2 weeks between groups.

Conclusion: This study failed to demonstrate any benefit of the adjunctive use of EMD in the reconstructive surgical therapy of peri-implantitis.

Trial registration: ISRCTN18159776 (https://doi.org/10.1186/ISRCTN18159776).

Keywords: bone regeneration; clinical trial; enamel matrix derivative; peri‐implant defect; peri‐implantitis; reconstructive therapy.

PubMed Disclaimer

References

    1. N. Donos, E. Calciolari, M. Ghuman, M. Baccini, V. Sousa, and L. Nibali, “The Efficacy of Bone Reconstructive Therapies in the Management of Peri‐Implantitis. A Systematic Review and Meta‐Analysis,” Journal of Clinical Periodontology 50, no. 26 (2023): 285–316, https://doi.org/10.1111/jcpe.13775.
    1. D. Herrera, T. Berglundh, F. Schwarz, et al., “Prevention and Treatment of Peri‐Implant Diseases—The EFP S3 Level Clinical Practice Guideline,” Journal of Clinical Periodontology 50, no. 26 (2023): 4–76, https://doi.org/10.1111/jcpe.13823.
    1. J. Derks, A. Ortiz‐Vigon, A. Guerrero, et al., “Reconstructive Surgical Therapy of Peri‐Implantitis: A Multicenter Randomized Controlled Clinical Trial,” Clinical Oral Implants Research 33, no. 9 (2022): 921–944, https://doi.org/10.1111/clr.13972.
    1. Y. Ichioka, A. Trullenque‐Eriksson, A. Ortiz‐Vigon, et al., “Factors Influencing Outcomes of Surgical Therapy of Peri‐Implantitis: A Secondary Analysis of 1‐Year Results From a Randomized Clinical Study,” Journal of Clinical Periodontology 50, no. 10 (2023): 1282–1304, https://doi.org/10.1111/jcpe.13848.
    1. E. Regidor, A. Ortiz‐Vigon, M. Romandini, C. Dionigi, J. Derks, and M. Sanz, “The Adjunctive Effect of a Resorbable Membrane to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: A Randomized Clinical Trial,” Journal of Clinical Periodontology 50, no. 6 (2023): 765–783, https://doi.org/10.1111/jcpe.13796.

LinkOut - more resources